Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy CollPlant Biotechnologies (CLGN) stock
Learn how to easily invest in CollPlant Biotechnologies stock.
CollPlant Biotechnologies Ltd is a biotechnology business based in the US. CollPlant Biotechnologies shares (CLGN) are listed on the NASDAQ and all prices are listed in US Dollars. CollPlant Biotechnologies employs 52 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in CollPlant Biotechnologies
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- CLGN shares summary
- Compare share dealing platforms
- Is CLGN stock a buy or sell?
- Stock performance over time
- Can I short CLGN shares?
- Are CLGN shares over-valued?
- CollPlant Biotechnologies's financials
- How volatile are CLGN shares?
- Does CollPlant Biotechnologies pay a dividend?
- Have CLGN shares ever split?
- Other common questions
CollPlant Biotechnologies stock price (NASDAQ: CLGN)Use our graph to track the performance of CLGN stocks over time.
CollPlant Biotechnologies shares at a glance
|Latest market close||$17.18|
|52-week range||$6.19 - $24.26|
|50-day moving average||$19.35|
|200-day moving average||$15.96|
|Wall St. target price||$23.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.74|
Buy CollPlant Biotechnologies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CollPlant Biotechnologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CollPlant Biotechnologies price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-17.86%|
|3 months (2021-04-28)||14.73%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Is CollPlant Biotechnologies under- or over-valued?
Valuing CollPlant Biotechnologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CollPlant Biotechnologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CollPlant Biotechnologies's P/E ratio
CollPlant Biotechnologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, CollPlant Biotechnologies shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CollPlant Biotechnologies's EBITDA
CollPlant Biotechnologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.8 million.
The EBITDA is a measure of a CollPlant Biotechnologies's overall financial performance and is widely used to measure a its profitability.
CollPlant Biotechnologies financials
|Revenue TTM||$20 million|
|Operating margin TTM||30.63%|
|Gross profit TTM||$3.1 million|
|Return on assets TTM||11.03%|
|Return on equity TTM||20.55%|
|Market capitalisation||$364.5 million|
TTM: trailing 12 months
Shorting CollPlant Biotechnologies shares
There are currently 20,374 CollPlant Biotechnologies shares held short by investors – that's known as CollPlant Biotechnologies's "short interest". This figure is 1102% up from 1,695 last month.
There are a few different ways that this level of interest in shorting CollPlant Biotechnologies shares can be evaluated.
CollPlant Biotechnologies's "short interest ratio" (SIR)
CollPlant Biotechnologies's "short interest ratio" (SIR) is the quantity of CollPlant Biotechnologies shares currently shorted divided by the average quantity of CollPlant Biotechnologies shares traded daily (recently around 92609.090909091). CollPlant Biotechnologies's SIR currently stands at 0.22. In other words for every 100,000 CollPlant Biotechnologies shares traded daily on the market, roughly 220 shares are currently held short.
However CollPlant Biotechnologies's short interest can also be evaluated against the total number of CollPlant Biotechnologies shares, or, against the total number of tradable CollPlant Biotechnologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CollPlant Biotechnologies's short interest could be expressed as 0% of the outstanding shares (for every 100,000 CollPlant Biotechnologies shares in existence, roughly 0 shares are currently held short) or 0.0021% of the tradable shares (for every 100,000 tradable CollPlant Biotechnologies shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CollPlant Biotechnologies.
Find out more about how you can short CollPlant Biotechnologies stock.
CollPlant Biotechnologies share dividends
We're not expecting CollPlant Biotechnologies to pay a dividend over the next 12 months.
Have CollPlant Biotechnologies's shares ever split?
CollPlant Biotechnologies's shares were split on a 2:3 basis on 20 November 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CollPlant Biotechnologies shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for CollPlant Biotechnologies shares which in turn could have impacted CollPlant Biotechnologies's share price.
CollPlant Biotechnologies share price volatility
Over the last 12 months, CollPlant Biotechnologies's shares have ranged in value from as little as $6.185 up to $24.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CollPlant Biotechnologies's is 0.7949. This would suggest that CollPlant Biotechnologies's shares are less volatile than average (for this exchange).
CollPlant Biotechnologies overview
CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissue; injectable implants to promote breast tissue regeneration; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has a co-development agreement with 3D Systems Corporation for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd.
Stocks similar to CollPlant Biotechnologies
CollPlant Biotechnologies in the news
Add a New Dimension to Your Growth Portfolio with 3D Systems
Add a New Dimension to Your Growth Portfolio with 3D Systems
Bioprinting Stocks: 3D Systems and Desktop Metal
Frequently asked questionsWhat percentage of CollPlant Biotechnologies is owned by insiders or institutions?
Currently 10.16% of CollPlant Biotechnologies shares are held by insiders and 12.234% by institutions. How many people work for CollPlant Biotechnologies?
Latest data suggests 52 work at CollPlant Biotechnologies. When does the fiscal year end for CollPlant Biotechnologies?
CollPlant Biotechnologies's fiscal year ends in December. Where is CollPlant Biotechnologies based?
CollPlant Biotechnologies's address is: Weizmann Science Park, Rehovot, Israel, 7670104 What is CollPlant Biotechnologies's ISIN number?
CollPlant Biotechnologies's international securities identification number is: US19516R1077 What is CollPlant Biotechnologies's CUSIP number?
CollPlant Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 19516Q208
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert